Re: rupturing the SF424 appendix Sarah Gause 30 Apr 2007 15:04 EST

That's been my interpretation.  In recent submissions, I've been adding
the  PubMed ID to the publications section of the Biosketches to the
articles we would have otherwise included (those published, but are not
free).
~Sarah

>>> xxxxxx@CORNELL.EDU 4/30/2007 3:54 PM >>>
Charlie,

I believe you are correct. At least this is my interpretation of the
notice published on November 17, 2006 (NOT-OD-07-018).  I have not read

the revised guide yet.

Cheers,

Pam

Pamela Plotkin, Ph.D.
Deputy Director of Sponsored Program Services
Cornell University
120 Day Hall
Ithaca, NY 14853
607-254-8329

Charlie Hathaway wrote:
> Re: NIH proposal appendices
> Is it correct that an investigator with, for example, 5 publications,
none of which are available via a free, online,
> publicly available journal link, may only attach 3 of these 5 in the
Appendix?
>
> See   Grants.gov  Application Guide  SF424 (R&R)
> Version 2 - I-107  (#7)  or  Version 2 - I-112  (#18)
>
> thanks
>
> Charlie
>
>
>
======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are
available
>  via our web site at http://www.hrinet.org (click on "Listserv
Lists")
>
======================================================================
>
>

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================